Related Experiment Video

Updated: Aug 15, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

[The role of TGF-beta in cell cycle regulation]

Liliana Stalińska1, Tomasz Ferenc

  • 1Zakład Biologii i Genetyki Uniwersytetu Medycznego, 90-647 Łódź. lstalinska@poczta.fm

Postepy Higieny I Medycyny Doswiadczalnej (Online)
|September 24, 2005
PubMed

Insights

Transforming growth factor-beta (TGFbeta) is a key regulator of cell growth, differentiation, and tissue repair. Dysregulation of TGFbeta signaling is implicated in various diseases, notably cancer.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Context:

  • Transforming growth factor-beta (TGFbeta) is a pleiotropic cytokine with diverse roles in cellular processes.
  • It influences cell proliferation, differentiation, apoptosis, and extracellular matrix production.
  • TGFbeta signaling is mediated by transmembrane Ser-Thr kinase receptors and the intracellular Smad pathway.

Purpose:

  • To summarize the multifaceted roles of TGFbeta in cellular functions.
  • To highlight the importance of TGFbeta signaling in physiological and pathological processes.
  • To underscore the link between TGFbeta pathway abnormalities and disease, particularly cancer.

Summary:

  • TGFbeta regulates cell cycle, growth, differentiation, apoptosis, angiogenesis, and epithelial-mesenchymal transition.
  • It signals via Ser-Thr kinase receptors to the Smad pathway, involving DNA-binding partners and transcriptional co-regulators.
  • Abnormal TGFbeta expression and mutations in its pathway are common in diseases, especially cancer.

Impact:

  • Understanding TGFbeta's functions is crucial for developing therapeutic strategies for diseases involving aberrant cell growth and tissue remodeling.
  • The TGFbeta pathway represents a significant target for cancer therapy due to its frequent dysregulation.
  • Further research into TGFbeta signaling can elucidate mechanisms of tissue repair and disease pathogenesis.

More Related Videos

Analysis of Cell Cycle Position in Mammalian Cells12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

Spheroid Assay to Measure TGF-β-induced Invasion09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...